SHELTON, Conn. (AP) — A company that is developing new anti-viral drugs hopes it will have a cure for Ebola, which is still in the research phase, put on the fast track for development in the fight against the disease.
NanoViricides, whose headquarters are in West Haven, opened its research and development lab in July. The company, with a net worth of $250 million, employs more than 20 and expects to double that in the next two years.
U.S. Sen. Richard Blumenthal, D-Conn., recently toured the newly renovated plant. He’s helping the company have its research evaluated by the U.S. Army Medical Research Institute of Infectious Diseases and, once a drug is developed, to move into clinical trials on an emergency basis.
AMRIID evaluates “different approaches to cures for various kind of diseases and they focus very intently on Ebola,” Blumenthal said. “We have expedited their attention on the work being done here.”